GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Beroni Group Ltd (OTCPK:BNIGF) » Definitions » Sloan Ratio %

Beroni Group (Beroni Group) Sloan Ratio % : 0.00% (As of Jun. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Beroni Group Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Beroni Group's Sloan Ratio for the quarter that ended in Jun. 2023 was 0.00%.

Warning Sign:

When sloan ratio (-50.89)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Jun. 2023, Beroni Group has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Beroni Group Sloan Ratio % Historical Data

The historical data trend for Beroni Group's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beroni Group Sloan Ratio % Chart

Beroni Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Sloan Ratio %
Get a 7-Day Free Trial 37.03 -28.60 -66.47 -5.43 -50.88

Beroni Group Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.00 -5.34 -19.94 -51.43 -

Competitive Comparison of Beroni Group's Sloan Ratio %

For the Conglomerates subindustry, Beroni Group's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beroni Group's Sloan Ratio % Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Beroni Group's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Beroni Group's Sloan Ratio % falls into.



Beroni Group Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Beroni Group's Sloan Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2022 )-Cash Flow from Operations (A: Dec. 2022 )
-Cash Flow from Investing (A: Dec. 2022 ))/Total Assets (A: Dec. 2022 )
=(-5.466--1.32
--0.582)/7.005
=-50.88%

Beroni Group's Sloan Ratio for the quarter that ended in Jun. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Jun. 2023 )
=(-6.459--0.903
--0.122)/6.053
=-89.77%

For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data. Beroni Group's Net Income for the trailing twelve months (TTM) ended in Jun. 2023 was -3.096 (Dec. 2022 ) + -3.363 (Jun. 2023 ) = $-6.46 Mil.
Beroni Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2023 was -0.327 (Dec. 2022 ) + -0.576 (Jun. 2023 ) = $-0.90 Mil.
Beroni Group's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2023 was -0.122 (Dec. 2022 ) + 0 (Jun. 2023 ) = $-0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beroni Group  (OTCPK:BNIGF) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Jun. 2023, Beroni Group has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Beroni Group Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Beroni Group's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Beroni Group (Beroni Group) Business Description

Traded in Other Exchanges
N/A
Address
Zhong Bei High Technology Industrial Park, Level 10, Building 11, Xiqing District, Tianjin, CHN, 300380
Beroni Group Ltd is an Australia based company engaged in the sale of smoking control product (NicoBloc), air purifier, healthcare products and supplements, cosmetics and stem-cell therapies. It has organized its business into four core business areas: cell therapies, developing new anticancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases. Its operating segment includes Nicobloc, Fogibloc air purifier, Olansi water filter, Health supplements, Cosmetic products, Viral diagnostic kits, and Technical advisory service. Geographically, it operates in China and Japan. The highest revenue is generated from the Nicobloc segment through the China region.